# The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis

> **NCT01587001** · NA · COMPLETED · sponsor: **National Jewish Health** · enrollment: 17 (actual)

## Conditions studied

- Pulmonary Sarcoidosis

## Interventions

- **DIETARY_SUPPLEMENT:** N-acetyl-cysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01587001
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587001, "The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01587001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*